By: Benzinga
Aegerion Pharmaceuticals Grants Stock Options to Purchase 55K Shares
Aegerion Pharmaceuticals (NASDAQ: AEGR ), a biopharmaceutical company dedicated to the development and commercialization of innovative, life-altering therapies for patients with debilitating and often fatal rare diseases, today announced that, on January 2, 2013, Aegerion granted stock options to purchase an aggregate of 55,000 shares of common stock to
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here